FIELD: biotechnology.
SUBSTANCE: method for diagnosing osteopetrosis, monogenic disease, type 4, under conditions of preimplantation genetic testing (PGT) is described. A test system has been developed for the diagnosis of pathogenic variants NC_000016.9:g.1499058A>T (NM_001287.5:c.1706T>A, p.Ile569Asn) and NC_000016.9:g.1510924C>T (NM_001287.5:c.377G>A, p.Arg126His0) in CLCN7 gene for use in the PGT of osteopetrosis, monogenic disease, type 4, with the possibility of direct and indirect diagnosis. The method has high specificity and efficiency, as well as versatility in relation to biosamples of various types: single cells, the product of whole genome amplification, total DNA isolated from different tissues.
EFFECT: method can be used not only for the detection of a specific pathogenic variant, but also for any other pathogenic variant or several in the CLCN7 gene using indirect detection.
1 cl, 2 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PREIMPLANTATION GENETIC TESTING METHOD FOR ACHONDROPLASIA | 2022 |
|
RU2795482C1 |
PREIMPLANTATION METHOD OF MARTINE-BELL SYNDROME GENETIC TESTING | 2022 |
|
RU2796834C1 |
METHOD FOR PREIMPLANTATION GENETIC TESTING OF SMITH-LEMLI-OPITZ SYNDROME | 2023 |
|
RU2816650C1 |
METHOD OF PREIMPLANTATION GENETIC TESTING OF HEREDITARY ZONULAR CATARACT | 2022 |
|
RU2799541C1 |
METHOD OF PREIMPLANTATION GENETIC TESTING FOR SPONDYLOEPIPHYSEAL DYSPLASIA | 2022 |
|
RU2803650C1 |
PREIMPLANTATION GENETIC TESTING METHOD FOR ALPORT SYNDROME | 2022 |
|
RU2795481C1 |
METHOD OF PREIMPLANTATION GENETIC TESTING OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY | 2023 |
|
RU2808833C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF BREAST AND OVARIAN CANCER | 2021 |
|
RU2777091C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF LOUIS-BAR SYNDROME | 2021 |
|
RU2777081C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF TYPE 1 FAMILIAL FOCAL EPILEPSY | 2021 |
|
RU2777084C1 |
Authors
Dates
2023-05-04—Published
2022-10-25—Filed